Central and Eastern Europe, Central Asia and the Caucasus are diverse, culturally rich and economically vibrant – offering significant investment potential alongside inherent risks. We closely monitor geopolitical shifts, regulatory changes and commercial opportunities to keep you ahead of the curve.
For over four decades, we have guided clients through complex legal challenges across the region. Our experts, with deep local knowledge, handle mergers and acquisitions, financings, restructurings, capital markets matters and disputes – including investor-state and commercial arbitrations – as well as EU competition matters.
Our global cross-border experience makes us the go-to adviser for multinationals investing in the region, while we also support local companies expanding internationally or accessing global financing. We recognize that one size does not fit all; our nuanced understanding of local legal, business and cultural dynamics sets us apart.
Where required, we work with trusted local firms and intermediaries. By bringing them into our team, we merge local insights with international experience to deliver tailored, seamless solutions that help you achieve your goals.
Freshfields advised Advent International (‘Advent’) in connection with its exclusive negotiations to acquire Zentiva, Sanofi’s European generics business for €1.9bn. Advent is a global investor, with over 25 years’ experience of investing in the healthcare sector. It has extensive experience of executing corporate carve-outs.
Contacts
